Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.

Stroke

From the Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan (K.H., H.S.); Division of Clinical Research Administration, Hokkaido University Hospital, Sapporo, Japan (H.S.); Department of Neurology, Okayama University Medical School, Japan (K.A., T. Yamashita); Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan (T.A., N.S.); Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai, Japan (M.D.); Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Japan (O.H., M.S.); Department of Neurosurgery, Nagasaki University Hospital, Japan (N.H., I.N.); Department of Neurology and Stroke Center, Tokyo General Hospital, Japan (Y.K.); Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan (Y.K., S.S.); Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan (K.K.); Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan (S.K.); Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Japan (T.M.); Neurorehabilitation Research Institute, Morinomiya Hospital, Osaka, Japan (I.M.); Department of Neurosurgery, Kokura Memorial Hospital, Kitakyushu, Japan (I.N.); Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan (K.N., T.T.); Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan (K. Sakushima, K. Sawanobori); Department of Regenerative Medicine Research, Institute of Biomedical Research and Innovation, Kobe, Japan (A.T.); Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center, Suita, Japan (H.Y.); Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan (T. Yoshimine); and Center for Information and Neural Networks, Osaka University, Suita, Japan (T. Yoshimine).

Published: April 2018

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.117.019216DOI Listing

Publication Analysis

Top Keywords

accelerating cell
4
cell therapy
4
therapy stroke
4
stroke japan
4
japan regulatory
4
regulatory framework
4
framework guidelines
4
guidelines development
4
development cell-based
4
cell-based products
4

Similar Publications

Cellular actin networks exhibit distinct assembly and disassembly dynamics, primarily driven by multicomponent reactions occurring at the two ends of actin filaments. While barbed ends are recognized as the hotspot for polymerization, depolymerization is predominantly associated with pointed ends. Consequently, mechanisms promoting barbed-end depolymerization have received relatively little attention.

View Article and Find Full Text PDF

Inhibition of mitochondrial energy production leads to reorganization of the plant endomembrane system.

Plant Physiol

January 2025

State Key Laboratory of Microbial Metabolism & Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China, P. R.

Mitochondria have generated the bulk of ATP to fuel cellular activities, including membrane trafficking, since the beginning of eukaryogenesis. How inhibition of mitochondrial energy production will affect the form and function of the endomembrane system and whether such changes are specific in today's cells remain unclear. Here, we treated Arabidopsis thaliana with antimycin A (AA), a potent inhibitor of the mitochondrial electron transport chain (mETC), as well as other mETC inhibitors and an uncoupler.

View Article and Find Full Text PDF

Insight into the Mechanism of d-Glucose Accelerated Exchange in GLUT1 from Molecular Dynamics Simulations.

Biochemistry

January 2025

BHF Centre of Research Excellence, School of Medicine and Life Sciences, King's College London, London SE1 9NH, United Kingdom.

Transmembrane glucose transport, facilitated by glucose transporters (GLUTs), is commonly understood through the simple mobile carrier model (SMCM), which suggests that the central binding site alternates exposure between the inside and outside of the cell, facilitating glucose exchange. An alternative "multisite model" posits that glucose transport is a stochastic diffusion process between ligand-operated gates within the transporter's central channel. This study aims to test these models by conducting atomistic molecular dynamics simulations of multiple glucose molecules docked along the central cleft of GLUT1 at temperatures both above and below the lipid bilayer melting point.

View Article and Find Full Text PDF

Background: Breast cancer remains a significant global health challenge, requiring innovative therapeutic strategies. In silico methods, which leverage computational tools, offer a promising pathway for vaccine development. These methods facilitate antigen identification, epitope prediction, immune response modelling, and vaccine optimization, accelerating the design process.

View Article and Find Full Text PDF

Although the role of low-level laser therapy (LLLT) and human adipose-derived stem cells (hADSC) in accelerating diabetic wound healing has been proven, their synergistic effect is still debated. This study aimed to evaluate the individual and combined effects of LLLT and hADSC on wound healing and on biomechanical parameters in type 2 diabetic rabbits. In this experimental study, 40 rabbits with type 2 diabetes (induced by streptozotocin (STZ)) were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!